The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Longitudinal tissue-based evaluation of TIGIT expression in patients with pancreatic cancer: Effect of expression with advancing clinical stages and across racial groups.
 
Madison George
No Relationships to Disclose
 
Julie Clark
No Relationships to Disclose
 
Kailee Hartway
No Relationships to Disclose
 
Samuel Zwernik
No Relationships to Disclose
 
Kendyll Gartrelle
No Relationships to Disclose
 
Daniel Sålas-Escabillas
No Relationships to Disclose
 
Daniel Long
No Relationships to Disclose
 
Georges Nassif
No Relationships to Disclose
 
Thais Pichardo
No Relationships to Disclose
 
Allison Wombwell
No Relationships to Disclose
 
Hui-Ju Wen
No Relationships to Disclose
 
Simone Benitz
No Relationships to Disclose
 
Philip A. Philip
Honoraria - AstraZeneca; Bayer; Blueprint Medicines; Bristol-Myers Squibb/Medarex; Celgene; Daiichi Sankyo/Astra Zeneca; Guardant Health; Guardant Health; incyte; Ipsen; Merck; Rafael Pharmaceuticals; SynCoreBio; TriSalus Life Sciences
Consulting or Advisory Role - Celgene; Daiichi Sankyo; Ipsen; Merck; SynCoreBio; Taiho Pharmaceutical; TriSalus Life Sciences
Speakers' Bureau - Bayer; Bristol-Myers Squibb/Medarex; Celgene; Incyte; Ipsen; Novartis
Research Funding - Advanced Accelerator Applications (Inst); ASLAN Pharmaceuticals (Inst); Bayer (Inst); boston biomedical (Inst); Caris Life Sciences (Inst); Caris Life Sciences (Inst); Genentech (Inst); halozyme (Inst); Immunomedics (Inst); incyte (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); merus (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); TYME (Inst); tyme (Inst)
Travel, Accommodations, Expenses - Abbvie; celgene; Rafael Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Caris MPI; Rafael Pharmaceuticals
 
Gazala Khan
No Relationships to Disclose
 
Rupen A. Shah
No Relationships to Disclose
 
Hakmin Park
No Relationships to Disclose
 
Howard Crawford
No Relationships to Disclose
 
David S. Kwon
No Relationships to Disclose
 
Brian Theisen
No Relationships to Disclose
 
Nina Steele
No Relationships to Disclose